Global Blood Virus Testing Market By Type (Full Blood Count Test, Test for Inflammation, Immunology Test, Liver Function Test, and VirScan Test), By Application (Hospitals, Diagnostic Centers, Clinics, and Ambulatory Surgical Centers), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- Published date: Jul 2022
- Report ID: 49060
- Number of Pages: 376
- Format:
- keyboard_arrow_up
- 1. Blood Virus Testing Market Introduction
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 2. Executive Summary
- 2.1. Key Findings by Major Segments
- 2.2. Top strategies by Major Players
- 3. Global Blood Virus Testing Market Overview
- 3.1. Blood Virus Testing Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Opportunities
- 3.1.3. Restraints
- 3.1.4. Challenges
- 3.2. PESTLE Analysis
- 3.3. Opportunity Map Analysis
- 3.4. PORTER'S Five Forces Analysis
- 3.5. Market Competition Scenario Analysis
- 3.6. Product Life Cycle Analysis
- 3.7. Opportunity Orbits
- 3.8. Production Analysis by Region/Company
- 3.9. Industry chain Analysis
- 3.10. Marketing Strategy
- 3.1. Blood Virus Testing Market Dynamics
- 4. Global Blood Virus Testing Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
- 4.1. Global Blood Virus Testing Market Analysis by Type: Introduction
- 4.2. Market Size and Forecast by Region
- 4.3. Full Blood Count Test
- 4.4. Test for Inflammation
- 4.5. Immunology Test
- 4.6. Liver Function Test
- 4.7. VirScan Test
- 5. Global Blood Virus Testing Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
- 5.1. Global Blood Virus Testing Market Analysis by Application: Introduction
- 5.2. Market Size and Forecast by Region
- 5.3. Hospitals
- 5.4. Diagnostic Centers
- 5.5. Clinics
- 5.6. Ambulatory Surgical Centers
- 6. Global Blood Virus Testing Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
- 6.1. North America
- 6.1.1. North America Blood Virus Testing Market: Regional Trend Analysis
- 6.1.1.1. US
- 6.1.1.2. Canada
- 6.1.1.3. Mexico
- 6.1.1. North America Blood Virus Testing Market: Regional Trend Analysis
- 6.2.1. Europe
- 6.2.1. Europe Blood Virus Testing Market: Regional Trend Analysis
- 6.2.1.1. Germany
- 6.2.1.2. France
- 6.2.1.3. UK
- 6.2.1.4. Russia
- 6.2.1.5. Italy
- 6.2.1.6. Spain
- 6.2.1.7. Rest of Europe
- 6.2.1. Europe Blood Virus Testing Market: Regional Trend Analysis
- 6.3. Asia-Pacific
- 6.3.1. Asia-Pacific Blood Virus Testing Market: Regional Trend Analysis
- 6.3.1.1. China
- 6.3.1.2. Japan
- 6.3.1.3. Korea
- 6.3.1.4. India
- 6.3.1.5. Rest of Asia-Pacific
- 6.3.1. Asia-Pacific Blood Virus Testing Market: Regional Trend Analysis
- 6.4. Latin America
- 6.4.1. Latin America Blood Virus Testing Market: Regional Trend Analysis
- 6.4.1.1. Brazil
- 6.4.1.2. Argentina
- 6.4.1.3. Rest of Latin America
- 6.4.1. Latin America Blood Virus Testing Market: Regional Trend Analysis
- 6.5. Middle East and Africa
- 6.5.1. Middle East and Africa Blood Virus Testing Market: Regional Trend Analysis
- 6.5.1.1. GCC
- 6.5.1.2. South Africa
- 6.5.1.3. Israel
- 6.5.1.4. Rest of MEA
- 6.5.1. Middle East and Africa Blood Virus Testing Market: Regional Trend Analysis
- 6.1. North America
- 7. Global Blood Virus Testing Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. F. Hoffmann-La Roche
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. bioM rieux
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. Bio-Rad Laboratories
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. Thermo Fisher Scientific
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. Omega Diagnostics Group
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. Randox Laboratories
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. OraSure Technologies
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- 1. Blood Virus Testing Market Introduction
- F. Hoffmann-La Roche
- bioM rieux
- Bio-Rad Laboratories, Inc. Company Profile
- Thermo Fisher Scientific Company Profile
- Omega Diagnostics Group
- Randox Laboratories
- OraSure Technologies
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible|
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
|---|---|---|---|
| e-Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |

